291 related articles for article (PubMed ID: 21193188)
1. Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome.
Soyman Z; Noyan V; Tulmac M; Yucel A; Sagsoz N; Bayrak T; Bayrak A; Cakir E
Fertil Steril; 2011 Mar; 95(3):1067-72. PubMed ID: 21193188
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.
Arikan S; Akay H; Bahceci M; Tuzcu A; Gokalp D
Fertil Steril; 2009 Feb; 91(2):450-5. PubMed ID: 18501898
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
[TBL] [Abstract][Full Text] [Related]
5. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
Brinkworth GD; Noakes M; Moran LJ; Norman R; Clifton PM
BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS.
Bayrak T; Dursun P; Bayrak A; Gültekin M; Kolusarı A; Cakır E; Ozyurt M; Zeyneloğlu HB
Gynecol Endocrinol; 2012 Nov; 28(11):874-8. PubMed ID: 22621680
[TBL] [Abstract][Full Text] [Related]
7. Subtle changes in ADMA and l-arginine concentrations in normal pregnancies are unlikely to account for pregnancy-related increased flow-mediated dilatation.
Saarelainen H; Valtonen P; Punnonen K; Laitinen T; Raitakari OT; Juonala M; Heiskanen N; Lyyra-Laitinen T; Viikari JS; Vanninen E; Heinonen S
Clin Physiol Funct Imaging; 2008 Mar; 28(2):120-4. PubMed ID: 18093231
[TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
[TBL] [Abstract][Full Text] [Related]
9. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.
Pepene CE; Ilie IR; Marian I; Duncea I
Eur J Endocrinol; 2011 Jan; 164(1):61-8. PubMed ID: 20974706
[TBL] [Abstract][Full Text] [Related]
10. No relationship between osteoprotegerin concentrations and endothelial dysfunction in non-obese women with and without polycystic ovary syndrome.
Abali R; Tasdemir N; Alpsoy S; Tasdemir UG; Guzel S; Yuksel MA; Temel Yuksel I; Yilmaz M
Arch Gynecol Obstet; 2015 May; 291(5):1075-80. PubMed ID: 25280574
[TBL] [Abstract][Full Text] [Related]
11. Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.
Sorensen MB; Franks S; Robertson C; Pennell DJ; Collins P
Clin Endocrinol (Oxf); 2006 Nov; 65(5):655-9. PubMed ID: 17054469
[TBL] [Abstract][Full Text] [Related]
12. Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study.
Mancini F; Cianciosi A; Reggiani GM; Facchinetti F; Battaglia C; de Aloysio D
Fertil Steril; 2009 Jun; 91(6):2537-44. PubMed ID: 18462732
[TBL] [Abstract][Full Text] [Related]
13. Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome.
Yildizhan R; Ilhan GA; Yildizhan B; Kolusari A; Adali E; Bugdayci G
Fertil Steril; 2011 Jul; 96(1):246-50. PubMed ID: 21600576
[TBL] [Abstract][Full Text] [Related]
14. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.
Kravariti M; Naka KK; Kalantaridou SN; Kazakos N; Katsouras CS; Makrigiannakis A; Paraskevaidis EA; Chrousos GP; Tsatsoulis A; Michalis LK
J Clin Endocrinol Metab; 2005 Sep; 90(9):5088-95. PubMed ID: 15985492
[TBL] [Abstract][Full Text] [Related]
15. Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome.
Pepene CE
Clin Endocrinol (Oxf); 2012 Jan; 76(1):119-25. PubMed ID: 21740456
[TBL] [Abstract][Full Text] [Related]
16. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome.
Mather KJ; Verma S; Corenblum B; Anderson TJ
J Clin Endocrinol Metab; 2000 May; 85(5):1851-6. PubMed ID: 10843164
[TBL] [Abstract][Full Text] [Related]
17. Metformin administration improves endothelial function in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Protogerou A; Piperi C; Papamichael C; Aessopos A; Lekakis J; Mavrikakis M
Eur J Endocrinol; 2005 May; 152(5):749-56. PubMed ID: 15879361
[TBL] [Abstract][Full Text] [Related]
18. The effects of laparoscopic ovarian drilling on flow mediated dilation in women with PCOS: relationship with insulin resistance and IGF-I.
Shokeir T; El-Kannishy G
Minerva Ginecol; 2014 Apr; 66(2):209-18. PubMed ID: 24848079
[TBL] [Abstract][Full Text] [Related]
19. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
Meyer C; McGrath BP; Teede HJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
[TBL] [Abstract][Full Text] [Related]
20. Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia.
Vladimirova-Kitova L; Deneva T; Angelova E; Nikolov F; Marinov B; Mateva N
Clin Physiol Funct Imaging; 2008 Nov; 28(6):417-25. PubMed ID: 18798847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
